Inicio \ Investigación \ Publicaciones científicas \

Antibiotic use in the COVID-19 crisis in Spain

Investigación publicada en Clinical Microbiology and Infection

1 de abril de 2021

Before the coronavirus disease 2019 (COVID-19) pandemic, antimicrobial resistance was the world`s most pressing health crisis. The United Nations, the World Health Organization (WHO) and the European Center for Disease Control and Prevention have made antimicrobial resistance a top priority, establishing a task force in the G-20 and organizing a joint program initiative on antimicrobial resistance including countries from al over the world [1]. However, with the emergence of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus pandemic in January 2020, all efforts are now focused on COVID-19, including controlling infections and developing vaccines

Gonzalez-Zorn B.

Ver artículo
Antibiotic use in the COVID-19 crisis in Spain

Ver en NLM PubMed
Antibiotic use in the COVID-19 crisis in Spain


Universidad ComplutenseServicio de Zoonosis de Transmisión Alimentaria y Resistencia a Antimicrobianos (ZTA). Centro de Vigilancia Sanitaria Veterinaria (VISAVET). Universidad Complutense (UCM).

Universidad ComplutenseDepartamento de Sanidad Animal. Facultad de Veterinaria. Universidad Complutense (UCM).

Clinical Microbiology and Infection
8.067 2020

NLMID: 9516420

PMID: 33248926

ISSN: 1198-743X

TÍTULO: Antibiotic use in the COVID-19 crisis in Spain

REVISTA: Clin. Microbiol. Infect.

NUMERACIÓN: 27(4):646-647

AÑO: 2021

EDITORIAL: Blackwell Scientific Publications

AUTORES: Gonzalez-Zorn B.


Bruno González Zorn



Gonzalez-Zorn B. Antibiotic use in the COVID-19 crisis in Spain. Clinical Microbiology and Infection. 27(4):646-647. 2021. (A). ISSN: 1198-743X. DOI: 10.1016/j.cmi.2020.09.055